Attached files
file | filename |
---|---|
10-K - Bohai Pharmaceuticals Group, Inc. | v197596_10k.htm |
EX-32.2 - Bohai Pharmaceuticals Group, Inc. | v197596_ex32-2.htm |
EX-31.2 - Bohai Pharmaceuticals Group, Inc. | v197596_ex31-2.htm |
EX-99.7 - Bohai Pharmaceuticals Group, Inc. | v197596_ex99-7.htm |
EX-31.1 - Bohai Pharmaceuticals Group, Inc. | v197596_ex31-1.htm |
Exhibit
32.1
CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION
1350
In
connection with the accompanying Annual Report on Form 10-K of Bohai
Pharmaceuticals Group, Inc. for the period ended June 30, 2010, I,
Hongwei Qu, Chief Executive Officer, hereby certifies pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:
1. Such
Annual Report on Form 10-K for the year ended June 30, 2010, fully complies with
the requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
2. The
information contained in such Annual Report on Form 10-K for the year ended June
30, 2010, fairly presents, in all material respects, the financial condition and
results of operations of Bohai Pharmaceuticals Group, Inc.
Dated:
September 28, 2010
/s/ Hongwei Qu
|
|
Hongwei
Qu
|
|
Chief
Executive Officer and
Chairman
|